Delivery Order SPE2DB24D3015-SPE2DB25FFXPV

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.70, is a Delivery Order for 32mg Hydromorphone HCl Extended Release Tablets. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,063 units of hydromorphone hydrochloride extended-release 16 mg tablets. The $1,281.96 firm fixed-price contract has a completion date of November 18, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,383.90 firm-fixed-price delivery order is for the supply of 4,566,640,143 tablets of 16 mg hydromorphone hydrochloride extended-release tablets. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $2,425.97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 8mg hydromorphone HCL extended-release tablets, a pain management medication. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,373.36 Firm Fixed Price Delivery Order is for the supply of 12mg hydromorphone HCL extended-release tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,010.30, is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets in quantities of 100. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,477.53, is for the delivery of Hydromorphone HCL ER Tablets 12 mg, a pain medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCD32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $4,207.56 firm fixed-price delivery order is for the supply of 16mg hydromorphone hydrochloride extended-release tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The U.S. government awarded a Delivery Order (DO) contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $7,832.23. The contract, with a completion date of April 17, 2023, is for the supply of Hydromorphone HCl ER Tablets 12mg to support medical needs. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,039.83 firm fixed-price contract is for the supply of hydromorphone 1 mg/ml vials, a pain management medication. The contract has an ultimate completion date of November 29, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXPV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 4/8/25, 9:49 AM